HCA Healthcare Inc (HCA) PT Lowered to $485 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts HCA Hot Sheet
Price: $462.34 -0.73%
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Scott Fidel lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $485.00 (from $558.00) while maintaining a Buy rating.
You May Also Be Interested In
- HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day
- Ally Financial (ALLY) PT Lowered to $52 at TD Cowen
- SpaceX (SPCX) PT Raised to $224 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
